Business
With a reputation as the ‘pharmacy of the world,’ India is geared to mass-produce COVID-19 vaccines – ABC News
India has become a global powerhouse for generic pharmaceutical drugs and the hope is that this could make Indian companies like the Serum Institute, which is the…
While the Pfizer COVID-19 vaccine rollout in the United Kingdom and the United States has been widely heralded as the beginning of the end of the pandemic, much of the developing world has its hopes set elsewhere.
India has become a global powerhouse for generic pharmaceutical drugs and accounts for about 60 per cent of the world’s vaccine supplies, earning a reputation as the “pharmacy of the world”.
And unlike the Pfizer vaccine which is safe and effective but relatively expensive and unstable…
-
Noosa News15 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business17 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Business22 hours agoIs AustralianSuper buying or selling Telstra and CSL shares?
-
Noosa News17 hours agoAnother whale calf caught in Noosa nets